You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 2023184014
Dec 20234505
Jan 20242003
Feb 20244201
Mar 20241800
Apr 20244001
May 20242401
Jun 20241402
Jul 20241200
Aug 20241000
Sep 20242000
Total429027